Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia

J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4509-e4519. doi: 10.1210/clinem/dgab446.

Abstract

Context: Several studies have highlighted the importance of the 11-oxygenated 19-carbon (11oxC19) adrenal-derived steroids as potential biomarkers for monitoring patients with 21-hydroxylase deficiency (21OHD).

Objective: To analyze circadian rhythmicity of 11oxC19 steroids in saliva profiles and evaluate their relevance as potential monitoring parameters in 21OHD.

Design, setting, and participants: Cross-sectional single-center study including 59 patients with classic 21OHD (men = 30; women = 29) and 49 body mass index- and age-matched controls (men = 19; women = 30).

Outcome measures: Salivary concentrations of the following steroids were analyzed by liquid chromatography-tandem mass spectrometry: 17-hydroxyprogesterone (17OHP), androstenedione (A4), testosterone (T), 11β-hydroxyandrostenedione (11OHA4), and 11-ketotestosterone (11KT).

Results: Similar to the previously described rhythmicity of 17OHP, 11OHA4 and 11KT concentrations followed a distinct diurnal rhythm in both patients and controls with highest concentrations in the early morning and declining throughout the day (11-OHA4: mean reduction of hormone concentrations between timepoint 1 and 5 (Δ mean) in male patients = 66%; male controls Δ mean = 83%; female patients Δ mean = 47%; female controls Δ mean = 86%; 11KT: male patients Δ mean = 57%; male controls Δ mean = 63%; female patients Δ mean = 50%; female controls Δ mean = 76%). Significant correlations between the area under the curve for 17OHP and 11KT (rpmale = 0.773<0.0001; rpfemale = 0.737<0.0001), and 11OHA4 (rpmale = 0.6330.0002; rpfemale = 0.5640.0014) were observed in patients but not present or reduced in controls.

Conclusions: Adrenal 11oxC19 androgens are secreted following a diurnal pattern. This should be considered when evaluating their utility for monitoring treatment control.

Keywords: 11-ketotestosterone; 11-oxygenated androgens; congenital adrenal hyperplasia; diurnal rhythm; saliva.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 17-alpha-Hydroxyprogesterone / analysis
  • Adrenal Hyperplasia, Congenital / drug therapy
  • Adrenal Hyperplasia, Congenital / metabolism*
  • Adult
  • Androgens / analysis*
  • Androgens / metabolism
  • Androstenedione / analogs & derivatives
  • Androstenedione / analysis
  • Biomarkers / analysis
  • Circadian Rhythm / physiology*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Male
  • Saliva / chemistry*
  • Testosterone / analogs & derivatives
  • Testosterone / analysis

Substances

  • Androgens
  • Biomarkers
  • Testosterone
  • Androstenedione
  • 11-hydroxyandrostenedione
  • 17-alpha-Hydroxyprogesterone
  • 11-ketotestosterone

Supplementary concepts

  • Congenital adrenal hyperplasia due to 21 hydroxylase deficiency